TRAIL/Apo-2L: Mechanisms and Clinical Applications in Cancer

Por Srivastava, Rakesh K
Publicado em 2001

Nutrition, diet and cancer

Por Shankar, Sharmila., Srivastava, Rakesh K.
Publicado em 2012

Stem Cells and Human Diseases

Por Srivastava, Rakesh K., Shankar, Sharmila.
Publicado em 2012

Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor

Por Shankar, Sharmila, Chen, Qinghe, Srivastava, Rakesh K
Publicado em 2008

EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C Nude mice through modulation of FKHRL1/FOXO3a and neuropilin

Por Shankar, Sharmila, Marsh, Luke, Srivastava, Rakesh K.
Publicado em 2012

Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms

Por Kumar, Dhruv, Shankar, Sharmila, Srivastava, Rakesh K
Publicado em 2013

Epigenetic Modifications by Dietary Phytochemicals: Implications for Personalized Nutrition

Por Shankar, Sharmila, Kumar, Dhruv, Srivastava, Rakesh K.
Publicado em 2012

Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells

Por Fandy, Tamer E, Shankar, Sharmila, Srivastava, Rakesh K
Publicado em 2008

Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer

Por Roy, Sanjit K, Srivastava, Rakesh K, Shankar, Sharmila
Publicado em 2010

Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications

Por Singh, Brahma N., Shankar, Sharmila, Srivastava, Rakesh K.
Publicado em 2011

FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol

Por Srivastava, Rakesh K., Unterman, Terry G., Shankar, Sharmila
Publicado em 2009

Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis

Por Shankar, Sharmila, Ganapathy, Suthakar, Chen, Qinghe, Srivastava, Rakesh K
Publicado em 2008

Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer

Por Kumar, Dhruv, Gupta, Dwijendra, Shankar, Sharmila, Srivastava, Rakesh K.
Publicado no Oncotarget (2014)

Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker

Por Yu, Wei, Ma, Yiming, Shankar, Sharmila, Srivastava, Rakesh K.
Publicado no Oncotarget (2016)

SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer

Por Yu, Wei, Ma, Yiming, Shankar, Sharmila, Srivastava, Rakesh K.
Publicado no Sci Rep (2017)

Chronic ethanol exposure of human pancreatic normal ductal epithelial cells induces cancer stem cell phenotype through SATB2

Por Yu, Wei, Ma, Yuming, Shankar, Sharmila, Srivastava, Rakesh K.
Publicado no J Cell Mol Med (2018)

Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms

Por Singh, Brahma N., Fu, Junsheng, Srivastava, Rakesh K., Shankar, Sharmila
Publicado em 2011

EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer

Por Tang, Su-Ni, Fu, Junsheng, Shankar, Sharmila, Srivastava, Rakesh K.
Publicado em 2012

Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential

Por Shankar, Sharmila, Chen, Qinghe, Siddiqui, Imtiaz, Sarva, Krishna, Srivastava, Rakesh K
Publicado em 2007

Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis

Por Shankar, Sharmila, Chen, Qinghe, Sarva, Krishna, Siddiqui, Imtiaz, Srivastava, Rakesh K
Publicado em 2007